Author

A. Shete

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 7 Research Focus:host-pathogen & immune response· 7 Organism:mouse· 4 Organism:human· 2 Assay:proteomics· 2 Organism:rat· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

P. Yadav· 7 shared P. Abraham· 6 shared N. Gupta· 5 shared S. Mohandas· 5 shared D. Nyayanit· 4 shared A. Kumar· 3 shared G. Deshpande· 3 shared G. Sapkal· 3 shared

Activity by Year

2020-2022 · peak 5/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

7 shared papersMicrobiology

P. Yadav

Mutual co-authors in cluster

Author profile →

7 papers

Recent·Most cited

Protective efficacy of COVAXIN(R) against Delta and Omicron variants in hamster model

P. Yadav, S. Mohandas, A. Shete, G. Sapkal, G. Deshpande, A. Kumar, K. Wakchaure, H. Dighe, R. Jain, B. Ganneru, J. Yemul, P. Gawande, K. M. Vadrevu, P. Abraham

This study evaluates COVAXIN's protective efficacy against Delta and Omicron variants in hamsters, showing improved protection with a third dose and reduced disease severity.

bioRxiv · Jun 14, 2022Immunology

ZRC3308 monoclonal antibody cocktail shows protective efficacy in Syrian hamsters against SARS-CoV-2 infection

P. Yadav, S. K. Mendiratta, S. Mohandas, A. K. Singh, P. Abraham, A. Shete, S. Bandhyopadhyay, S. Kumar, A. Parikh, P. Kalita, V. Sharma, H. Pandya, C. G. Patel, M. Patel, S. Soni, , M. Jain

The paper develops a monoclonal antibody cocktail (ZRC-3308) effective against multiple SARS-CoV-2 variants in Syrian hamsters.

bioRxiv · Sep 16, 2021Microbiology

Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model

P. Yadav, S. Mohandas, P. Sarkale, D. Nyayanit, A. Shete, R. Sahay, V. Potdar, S. Baradkar, N. Gupta, G. Sapkal, P. Abraham, S. Panda, B. Bhargava

The paper isolates the SARS-CoV-2 B.1.1.28.2 (P.2) variant from travelers and compares its pathogenicity to the D614G variant in hamsters, finding it more severe and with reduced neutralization.

bioRxiv · May 24, 2021Microbiology

Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travelers

P. Yadav, P. Sarkale, A. Razdan, N. Gupta, D. Nyayanit, R. Sahay, V. Potdar, D. Patil, S. Baradkar, A. Kumar, N. Aggarwal, A. Shete, H. Kaur

The paper isolates and characterizes the SARS-CoV-2 VOC 20H/501Y.V2 (B.1.351) from UAE travelers to India to assess vaccine efficacy.

bioRxiv · May 14, 2021 · PreprintMicrobiology

Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1

P. Yadav, G. N. Sapkal, P. Abraham, G. Deshpande, D. Nyayanit, D. Y. Patil, N. Gupta, R. R. Sahay, A. Shete, S. Kumar, S. Panda, B. Bhargava

This study compares neutralizing antibody responses in Covishield-vaccinated individuals and COVID-19 recovered subjects against B.1 and B.1.617.1 variants, finding higher neutralization in recovered subjects.

bioRxiv · May 12, 2021Immunology

Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection

P. Yadav, S. Kumar, K. Agarwal, M. Jain, D. Patil, K. Maithal, B. Mathapati, S. Giri, S. Mohandas, A. Shete, G. Sapkal, D. Patil, A. Dey, H. Chandra, G. Deshpande, , P. Abraham

This study evaluates two doses of ZyCoV-D DNA vaccine in rhesus macaques, finding that the 2mg dose via Needle Free Injection System provides better immune response and protection against SARS-CoV-2.

bioRxiv · Feb 2, 2021 · PreprintMicrobiology

Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152

B. Ganneru, H. Jogdand, V. K. Dharam, N. Reddy, S. D. Prasad, S. Vellimudu, K. M. Ella, R. Ravikrishnan, A. Awasthi, J. Jose, P. Rao, D. Kumar, R. Ella, P. Abraham, P. Yadav, , K. V. Mohan

This study evaluates the safety and immunogenicity of a SARS-CoV-2 vaccine BBV152 in mice, rats, and rabbits, showing high antibody titers and Th1-biased responses with the TLR7/8 agonist adjuvant.

bioRxiv · Sep 9, 2020 · PreprintImmunology